David Domzalski

Insider Reports History

Location
Rehovot, Israel
Signature
/s/ Mutya Harsch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Domzalski:

Company Role Class Num Shares Value Price $ Report Date Ownership
VYNE Therapeutics Inc. PRESIDENT AND CEO, Director Common Stock 416,208 $241,442 $0.5801 31 Dec 2025 Direct
VYNE Therapeutics Inc. PRESIDENT AND CEO, Director Stock Option (right to buy) 730,000 21 Jan 2025 Direct

Insider Reports Filed by David Domzalski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VYNE VYNE Therapeutics Inc. 31 Dec 2025 1 -$7,358 4 PRESIDENT AND CEO, Director 05 Jan 2026, 08:30
VYNE VYNE Therapeutics Inc. 30 Sep 2025 1 -$4,246 4 PRESIDENT AND CEO, Director 02 Oct 2025, 17:05
VYNE VYNE Therapeutics Inc. 30 Jun 2025 1 -$20,915 4 PRESIDENT AND CEO, Director 02 Jul 2025, 16:30
VYNE VYNE Therapeutics Inc. 02 Jun 2025 1 +$7,032 4 PRESIDENT AND CEO, Director 03 Jun 2025, 16:15
VYNE VYNE Therapeutics Inc. 31 Mar 2025 1 -$48,187 4 PRESIDENT AND CEO, Director 02 Apr 2025, 16:15
VYNE VYNE Therapeutics Inc. 21 Jan 2025 1 $0 4 PRESIDENT AND CEO, Director 23 Jan 2025, 16:15
VYNE VYNE Therapeutics Inc. 31 Dec 2024 1 -$82,196 4 PRESIDENT AND CEO, Director 02 Jan 2025, 17:45
VYNE VYNE Therapeutics Inc. 30 Nov 2024 1 +$8,192 4 PRESIDENT AND CEO, Director 03 Dec 2024, 16:15
VYNE VYNE Therapeutics Inc. 30 Sep 2024 1 -$1,288 4 PRESIDENT AND CEO, Director 02 Oct 2024, 16:15
VYNE VYNE Therapeutics Inc. 01 Jul 2024 1 -$1,795 4 PRESIDENT AND CEO, Director 03 Jul 2024, 16:15
VYNE VYNE Therapeutics Inc. 31 May 2024 1 +$9,562 4 PRESIDENT AND CEO, Director 04 Jun 2024, 16:30
VYNE VYNE Therapeutics Inc. 01 Apr 2024 1 -$3,092 4 PRESIDENT AND CEO, Director 03 Apr 2024, 17:02
VYNE VYNE Therapeutics Inc. 01 Jan 2024 3 -$2,289 4 President and CEO, Director 03 Jan 2024, 17:17
VYNE VYNE Therapeutics Inc. 13 Dec 2023 2 $0 4 President and CEO, Director 15 Dec 2023, 17:08
VYNE VYNE Therapeutics Inc. 30 Nov 2023 1 +$6,426 4 President and CEO, Director 04 Dec 2023, 16:30
VYNE VYNE Therapeutics Inc. 02 Oct 2023 1 -$32,743 4 President and CEO, Director 04 Oct 2023, 16:19
VYNE VYNE Therapeutics Inc. 30 Jun 2023 1 -$4,022 4 President and CEO, Director 05 Jul 2023, 16:30
VYNE VYNE Therapeutics Inc. 31 May 2023 1 +$9,560 4 President and CEO, Director 02 Jun 2023, 16:31
VYNE VYNE Therapeutics Inc. 31 Mar 2023 1 -$8,421 4 President and CEO, Director 04 Apr 2023, 17:01
VYNE VYNE Therapeutics Inc. 31 Dec 2022 1 -$1,603 4 President and CEO, Director 04 Jan 2023, 16:03
VYNE VYNE Therapeutics Inc. 30 Nov 2022 1 +$6,861 4 President and CEO, Director 02 Dec 2022, 15:30
VYNE VYNE Therapeutics Inc. 30 Sep 2022 1 -$2,382 4 President and CEO, Director 04 Oct 2022, 17:00
VYNE VYNE Therapeutics Inc. 30 Jun 2022 1 -$4,156 4 President and CEO, Director 05 Jul 2022, 17:00
VYNE VYNE Therapeutics Inc. 31 May 2022 1 +$4,116 4 President and CEO, Director 02 Jun 2022, 16:35
VYNE VYNE Therapeutics Inc. 31 Mar 2022 1 -$15,071 4 President and CEO, Director 04 Apr 2022, 17:08
VYNE VYNE Therapeutics Inc. 17 Mar 2022 2 $0 4 President and CEO, Director 18 Mar 2022, 17:09
VYNE VYNE Therapeutics Inc. 31 Dec 2021 1 -$7,025 4 President and CEO, Director 04 Jan 2022, 15:39
VYNE VYNE Therapeutics Inc. 30 Nov 2021 1 +$4,119 4 President and CEO, Director 02 Dec 2021, 16:07
VYNE VYNE Therapeutics Inc. 30 Sep 2021 1 -$18,203 4 President and CEO, Director 01 Oct 2021, 17:10
VYNE VYNE Therapeutics Inc. 02 Sep 2021 2 $0 4 President and CEO, Director 03 Sep 2021, 17:33
VYNE VYNE Therapeutics Inc. 30 Jun 2021 1 -$66,195 4 President and CEO, Director 02 Jul 2021, 16:35
VYNE VYNE Therapeutics Inc. 28 May 2021 1 +$3,159 4 President and CEO, Director 02 Jun 2021, 16:30